These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6471933)
1. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage. Edwards RH; Jones DA; Jackson MJ Med Biol; 1984; 62(2):143-7. PubMed ID: 6471933 [No Abstract] [Full Text] [Related]
2. Techniques for studying free radical damage in muscular dystrophy. Jackson MJ; Jones DA; Edwards RH Med Biol; 1984; 62(2):135-8. PubMed ID: 6471931 [No Abstract] [Full Text] [Related]
3. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086 [TBL] [Abstract][Full Text] [Related]
4. [Duchenne Boulogne myopathy and free radicals; potential value of lazaroids in the treatment of this disease]. Poindron P; Metzinger L; Warter JM C R Seances Soc Biol Fil; 1995; 189(6):1199-217. PubMed ID: 8763042 [No Abstract] [Full Text] [Related]
5. Vitamin E: the radical protector. Wolf R; Wolf D; Ruocco V J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):103-17. PubMed ID: 9553906 [TBL] [Abstract][Full Text] [Related]
6. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E. Airenne AL; Westermarck T Med Biol; 1984; 62(2):154. PubMed ID: 6471936 [No Abstract] [Full Text] [Related]
7. [Free radical retinal damage in rabbits of experimental acute ocular hypertension]. Zhao GQ Zhonghua Yan Ke Za Zhi; 1993 Sep; 29(5):293-5. PubMed ID: 8168396 [TBL] [Abstract][Full Text] [Related]
8. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence]. Pizarro M; Lissi E; Reyes J; Holmgren J Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087 [TBL] [Abstract][Full Text] [Related]
9. [Our experience in the treatment of progressive muscular dystrophy]. Buscaino GA Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587 [No Abstract] [Full Text] [Related]
10. Adjunctive vitamin E treatment in Wilson disease and suggestions for future trials. Shen L; Ji HF Hepatology; 2010 May; 51(5):1864; author reply 1864-5. PubMed ID: 20432273 [No Abstract] [Full Text] [Related]
11. Free radicals and trials of antioxidant therapy in muscle diseases. Jackson MJ; Edwards RH Adv Exp Med Biol; 1990; 264():485-91. PubMed ID: 2244529 [No Abstract] [Full Text] [Related]
12. Contribution to the muscular dystrophy treatment. Tomaszkiewicz JA; Kossatz-Bielecka DE Pol Med Sci Hist Bull; 1968 Apr; 11(2):92. PubMed ID: 4870251 [No Abstract] [Full Text] [Related]
14. [Therapeutic possibilities in progressive muscular dystrophy]. Beckmann R; von Osten V Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816 [No Abstract] [Full Text] [Related]
15. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy]. Radu H; Stenzel K; Blücher G; Gödri I Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160 [No Abstract] [Full Text] [Related]
16. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy. Buscaino GA; Caruso G Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733 [No Abstract] [Full Text] [Related]
17. [Antioxidant vitamins in the treatment and prevention of cardiovascular diseases. Vitamin E]. Spirichev VB Vopr Pitan; 2003; 72(6):45-51. PubMed ID: 14870590 [TBL] [Abstract][Full Text] [Related]
19. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine. Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457 [TBL] [Abstract][Full Text] [Related]
20. A trial of selenium and vitamin E in boys with muscular dystrophy. Gamstorp I; Gustavson KH; Hellström O; Nordgren B J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]